Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLLS Cellectis S.A.

已收盘 11-22 16:00:00 EST

1.87

+0.01

+0.54%

盘后1.88

+0.01+0.53%

16:00 EST

最高1.89	最低1.85	成交量2.98万
今开1.86	昨收1.86	日振幅2.15%
总市值1.87亿	流通市值1.34亿	总股本1.00亿
成交额5.55万	换手率0.04%	流通股本7,146万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLLS","market":"US","secType":"STK","nameCN":"Cellectis S.A.","latestPrice":1.87,"timestamp":1732309200000,"preClose":1.86,"halted":0,"volume":29798,"hourTrading":{"tag":"盘后","latestPrice":1.88,"preClose":1.87,"latestTime":"16:00 EST","volume":26,"amount":48.879999999999995,"timestamp":1732309203291},"delay":0,"floatShares":71463341,"shares":100093873,"eps":-1.035365,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"11-22 16:00:00 EST","open":1.86,"high":1.89,"low":1.85,"amount":55463.90836,"amplitude":0.021505,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.035365,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":1,"listingDate":1427256000000,"adjPreClose":1.86,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":1.83,"preClose":1.88,"latestTime":"04:11 EST","volume":300,"amount":552,"timestamp":1732266698430},"postHourTrading":{"tag":"盘后","latestPrice":1.88,"preClose":1.87,"latestTime":"16:00 EST","volume":26,"amount":48.879999999999995,"timestamp":1732309203291},"volumeRatio":0.36937,"impliedVol":1.5169,"impliedVolPercentile":0.9286},"requestUrl":"/m/hq/s/CLLS","defaultTab":"news","newsList":[{"id":"2484988338","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.35%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484988338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484988338?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:27","pubTimestamp":1731958073,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时27分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速上涨5.35%。截至发稿，该股报1.97美元/股，成交量17.0066万股，换手率0.17%，振幅6.42%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032753971a7429&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032753971a7429&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2483056163","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大跌5.24%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483056163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483056163?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:45","pubTimestamp":1731685503,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时45分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速跳水5.24%。截至发稿，该股报1.81美元/股，成交量6741股，换手率0.01%，振幅5.24%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为3.26%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523450398e42fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523450398e42fe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2483388111","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌6.06%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483388111?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:34","pubTimestamp":1731598487,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时34分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅跳水6.06%。截至发稿，该股报1.86美元/股，成交量2177股，换手率0.00%，振幅2.33%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.75%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114233448a237f447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114233448a237f447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS","BK4007","PULM","ELAB","BK4183"],"gpt_icon":0},{"id":"2482732807","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482732807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482732807?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:18","pubTimestamp":1731341896,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时18分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅上涨5.08%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.00%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112001816971a5c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112001816971a5c34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2482979427","title":"Cellectis Ads Each Repr 1 Ord Spon2024财年第三财季实现净利润-23.06百万美元，同比减少31.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482979427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482979427?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:03","pubTimestamp":1731168228,"startTime":"0","endTime":"0","summary":"11月10日，Cellectis Ads Each Repr 1 Ord Spon公布财报，公告显示公司2024财年第三财季净利润为-23.06百万美元，同比减少31.92%；其中营业收入为16.20百万美元，同比增加10351.61%，每股基本收益为-0.23美元。从资产负债表来看，Cellectis Ads Each Repr 1 Ord Spon总负债2.66亿美元，其中短期债务13.86百万美元，资产负债比为1.49，流动比率为1.78。机构评级：截至2024年11月10日，当前有7家机构对Cellectis Ads Each Repr 1 Ord Spon目标价做出预测，其中目标均价为6.29美元，其中最低目标价为3.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000453a22787aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000453a22787aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS"],"gpt_icon":0},{"id":"2481886766","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481886766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481886766?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:31","pubTimestamp":1730817077,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速拉升7.95%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Elevai Labs, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Elevai Labs, Inc.较为活跃，换手率分别为2181.06%、847.64%、395.62%，振幅较大的相关个股有Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Renovaro Inc.，振幅分别为25.26%、9.88%、7.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522311795bdd1b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522311795bdd1b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2479259155","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 临近收盘股价大跌6.74%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479259155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479259155?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:57","pubTimestamp":1730231861,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时57分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速跳水6.74%。截至发稿，该股报1.80美元/股，成交量19.1522万股，换手率0.19%，振幅6.74%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030035741971a301d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030035741971a301d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2478262930","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速下跌5.22%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478262930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478262930?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:36","pubTimestamp":1729870565,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时36分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速跳水5.22%。截至发稿，该股报1.80美元/股，成交量8406股，换手率0.01%，振幅3.49%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.61%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025233605971a25dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025233605971a25dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2477552434","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速上涨5.00%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477552434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477552434?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:46","pubTimestamp":1729705573,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时46分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅拉升5.00%。截至发稿，该股报1.89美元/股，成交量24.0893万股，换手率0.24%，振幅5.53%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为1.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024014614ab6df5f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024014614ab6df5f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2474225018","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速上涨5.10%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474225018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474225018?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:46","pubTimestamp":1728481595,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时46分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速拉升5.10%。截至发稿，该股报2.06美元/股，成交量6245股，换手率0.01%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.66%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410092146369719f44b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410092146369719f44b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139","IKT"],"gpt_icon":0},{"id":"2473109325","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨8.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473109325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473109325?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:41","pubTimestamp":1728308496,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时41分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速拉升8.69%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.06%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721413798e3ada1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721413798e3ada1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2472461680","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘急速上涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472461680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472461680?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:32","pubTimestamp":1727962339,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时32分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速拉升6.12%。截至发稿，该股报2.08美元/股，成交量1099股，换手率0.00%，振幅0.51%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.27%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003213220958dc5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003213220958dc5eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183","BK4139","CLLS"],"gpt_icon":0},{"id":"2472558170","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 临近收盘快速下跌5.10%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472558170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472558170?lang=zh_cn&edition=full","pubTime":"2024-10-02 03:41","pubTimestamp":1727811714,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日03时41分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速下挫5.10%。截至发稿，该股报2.01美元/股，成交量3.4414万股，换手率0.03%，振幅5.19%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100203415498e3a07c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100203415498e3a07c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2460004059","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460004059","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460004059?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:40","pubTimestamp":1724161243,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时40分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅拉升6.10%。截至发稿，该股报2.26美元/股，成交量5520股，换手率0.01%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.23%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820214043ab5ea361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820214043ab5ea361&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2459081031","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大跌5.34%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459081031","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459081031?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:02","pubTimestamp":1723644170,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时02分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速下跌5.34%。截至发稿，该股报1.95美元/股，成交量3.5697万股，换手率0.04%，振幅4.85%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.37%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142202519682639c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142202519682639c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2457868071","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速上涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457868071","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457868071?lang=zh_cn&edition=full","pubTime":"2024-08-07 01:08","pubTimestamp":1722964089,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日01时08分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅拉升5.81%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.78%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807010810af96371e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807010810af96371e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2456456476","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速下挫5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456456476","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456456476?lang=zh_cn&edition=full","pubTime":"2024-08-02 00:47","pubTimestamp":1722530857,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日00时47分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速下跌5.35%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.77%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802004737af9566b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802004737af9566b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2455661587","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速下挫5.19%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455661587","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455661587?lang=zh_cn&edition=full","pubTime":"2024-07-29 22:32","pubTimestamp":1722263530,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日22时32分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅下跌5.19%。截至发稿，该股报2.18美元/股，成交量3.0909万股，换手率0.03%，振幅3.91%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729223210aefbfbd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729223210aefbfbd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2454328500","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨7.32%报2.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454328500","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454328500?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:32","pubTimestamp":1722000765,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时32分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速拉升7.32%。截至发稿，该股报2.20美元/股，成交量9.4926万股，换手率0.09%，振幅0.98%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213245955d93d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213245955d93d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2452840403","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大跌5.09%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452840403","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452840403?lang=zh_cn&edition=full","pubTime":"2024-07-19 23:27","pubTimestamp":1721402833,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日23时27分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速跳水5.09%。截至发稿，该股报2.05美元/股，成交量1757股，换手率0.00%，振幅2.13%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.03%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719232714af9332cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719232714af9332cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139","VRPX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectis.com","stockEarnings":[{"period":"1week","weight":-0.0262},{"period":"1month","weight":0.0333},{"period":"3month","weight":-0.2152},{"period":"6month","weight":-0.3404},{"period":"1year","weight":-0.3404},{"period":"ytd","weight":-0.3961}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectis S.A.于2000年1月4日成立。该公司是一家处于临床阶段的生物技术公司，利用他们的核心专有技术开发基于基因编辑的产品，拥有一系列同种异体嵌合抗原受体T细胞，即免疫肿瘤学领域的候选产品和基因编辑造血干细胞和祖细胞，即HSPC，其他治疗适应症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.004346},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.066082},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.033625},{"month":4,"riseRate":0.3,"avgChangeRate":-0.001702},{"month":5,"riseRate":0.7,"avgChangeRate":0.070474},{"month":6,"riseRate":0.2,"avgChangeRate":-0.087784},{"month":7,"riseRate":0.3,"avgChangeRate":-0.01954},{"month":8,"riseRate":0.7,"avgChangeRate":0.059564},{"month":9,"riseRate":0.1,"avgChangeRate":-0.130295},{"month":10,"riseRate":0.4,"avgChangeRate":-0.073969},{"month":11,"riseRate":0.5,"avgChangeRate":0.235415},{"month":12,"riseRate":0.555556,"avgChangeRate":0.010762}],"exchange":"NASDAQ","name":"Cellectis S.A.","nameEN":"Cellectis SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectis S.A.(CLLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectis S.A.,CLLS,Cellectis S.A.股票,Cellectis S.A.股票老虎,Cellectis S.A.股票老虎国际,Cellectis S.A.行情,Cellectis S.A.股票行情,Cellectis S.A.股价,Cellectis S.A.股市,Cellectis S.A.股票价格,Cellectis S.A.股票交易,Cellectis S.A.股票购买,Cellectis S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectis S.A.(CLLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}